tirzepatide diabetes trial monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 (SURPASS-CN-MONO) Frias_Tirzepatide: Overview of SURPASS Trials
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5


























